Association of preoperative infections, nasal Staphylococcus aureus colonization and gut microbiota with left ventricular assist device outcomes.


Journal

European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595

Informations de publication

Date de publication:
08 2021
Historique:
revised: 29 03 2021
received: 22 01 2021
accepted: 04 05 2021
pubmed: 9 5 2021
medline: 25 9 2021
entrez: 8 5 2021
Statut: ppublish

Résumé

Infections are common following left ventricular assist device (LVAD) implantation and predict adverse events. Infections are frequent prior to LVAD implantation although their impact on postoperative outcomes remains unknown. Gut and nasal microbial imbalance may predispose to mucosal colonization with pathogens. Herein, we investigated the predictive role of pre-LVAD infections, and explored the association of nasal Staphylococcus aureus (SA) colonization and gut microbiota, on postoperative outcomes. Overall, 254 LVAD patients were retrospectively categorized based on pre-LVAD infection status: Group 1, bacterial/fungal bloodstream infection (BSI); Group 2, other bacterial/fungal; Group 3, viral; and Group 4, no infection. In a subset of patients, nasal SA colonization (n = 140) and pre-LVAD stool (n = 25) were analysed using 16S rRNA sequencing. A total of 75 (29%) patients had a pre-LVAD infection [Group 1: 22 (29%); Group 2: 41 (55%); Group 3: 12 (16%)]. Pre-LVAD BSIs were independent predictors of 1-year postoperative mortality and infections [Group 1 vs. 4: hazard ratio (HR) 2.70, P = 0.036 vs. HR 1.8, P = 0.046]. In an unadjusted analysis, pre-LVAD infections other than BSIs, INTERMACS profile ≤2, higher serum creatinine, lower serum albumin and nasal SA colonization were also significantly associated with postoperative infections. Patients with early post-LVAD infections exhibited decreased microbial diversity (P < 0.05). Pre-LVAD infections are common. BSIs independently predict postoperative mortality and infections. Additional studies are needed to confirm our findings that pre-LVAD SA nasal colonization and gut microbial composition can help stratify patients' risk for infectious complications after LVAD implantation.

Identifiants

pubmed: 33964186
doi: 10.1002/ejhf.2215
pmc: PMC8893141
mid: NIHMS1782899
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1404-1415

Subventions

Organisme : NHLBI NIH HHS
ID : T32 HL007854
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© 2021 European Society of Cardiology.

Références

Int J Cardiol. 2006 Aug 28;111(3):405-12
pubmed: 16271779
F1000Res. 2016 Jun 24;5:1492
pubmed: 27508062
Circulation. 2013 Feb 12;127(6):691-702
pubmed: 23315371
J Card Surg. 2019 Feb;34(2):82-91
pubmed: 30710496
Ann Thorac Surg. 2003 Jun;75(6 Suppl):S58-65
pubmed: 12820736
Circ Res. 2019 Jan 4;124(1):94-100
pubmed: 30582442
Am J Infect Control. 2008 Jun;36(5):309-32
pubmed: 18538699
J Heart Lung Transplant. 2017 Oct;36(10):1137-1153
pubmed: 28781010
Gut. 2011 May;60(5):631-7
pubmed: 21209126
J Cardiothorac Vasc Anesth. 2012 Dec;26(6):1094-100
pubmed: 22765993
J Clin Biochem Nutr. 2018 Jul;63(1):33-35
pubmed: 30087541
J Am Coll Cardiol. 2018 Mar 13;71(10):1184-1186
pubmed: 29519360
Sci Adv. 2015 Jun 05;1(5):e1400216
pubmed: 26601194
J Heart Lung Transplant. 2019 Apr;38(4):364-373
pubmed: 30733158
Am J Med. 2008 Apr;121(4):310-5
pubmed: 18374690
J Heart Lung Transplant. 2020 Aug;39(8):774-781
pubmed: 32276809
Ann Thorac Surg. 2008 May;85(5):1656-61
pubmed: 18442560
Am J Respir Crit Care Med. 2016 Aug 15;194(4):450-63
pubmed: 26886180
N Engl J Med. 2019 Apr 25;380(17):1618-1627
pubmed: 30883052
Genome Biol. 2014;15(12):550
pubmed: 25516281
ESC Heart Fail. 2017 Aug;4(3):282-290
pubmed: 28772054
World J Gastroenterol. 2019 May 14;25(18):2149-2161
pubmed: 31143067
Circ Heart Fail. 2020 May;13(5):e006746
pubmed: 32354281
ISME J. 2017 Dec;11(12):2639-2643
pubmed: 28731476
J Heart Lung Transplant. 2020 Sep;39(9):880-890
pubmed: 32139154
Science. 2019 Nov 15;366(6467):881-886
pubmed: 31727837
JACC Heart Fail. 2016 Mar;4(3):208-17
pubmed: 26746378
Am J Cardiol. 2015 Jan 1;115(1):57-61
pubmed: 25456873
ASAIO J. 2019 Nov/Dec;65(8):798-805
pubmed: 30234503
Genome Med. 2016 May 26;8(1):61
pubmed: 27229935

Auteurs

Melana Yuzefpolskaya (M)

Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.

Heidi S Lumish (HS)

Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.

Azka Javaid (A)

Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.

Barbara Cagliostro (B)

Division of Cardiac Surgery, Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA.

Giulio M Mondellini (GM)

Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.

Bruno Bohn (B)

Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA.

Austin Sweat (A)

Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.

Duygu Onat (D)

Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.

Lorenzo Braghieri (L)

Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.

Koji Takeda (K)

Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA.

Yoshifumi Naka (Y)

Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA.

Gabriel T Sayer (GT)

Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.

Nir Uriel (N)

Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.

Justin G Aaron (JG)

Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.

Emmanuel Montassier (E)

Department of Computer Science and Engineering, University of Minnesota, Minneapolis, MN, USA.
Université de Nantes, Microbiotas Hosts Antibiotics and Bacterial Resistances (MiHAR), and Department of Emergency Medicine, CHU de Nantes, Nantes, France.

Ryan T Demmer (RT)

Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA.
Department of Epidemiology, Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY, USA.

Paolo C Colombo (PC)

Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH